Skip to content
This event took place on 16th April 2020, so you won't be able to enquire. They may run the event again in the future. Contact the member by visiting their profile using the 'Member Profile' link above.

NASH is becoming a leading cause for end-stage liver disease and liver transplant. The presence of advanced fibrosis is a key predictor of liver-related morbidity and mortality and represents a significant unmet clinical need in terms of timely recognition and effective treatment. A faculty of experts in NASH; Professor Arun Sanyal; Professor Jörn Schattenberg; Professor Laurent Castera and; Ms Livia Alimena of the Global Liver Institute; will deliver this educational and interactive symposium. They will discuss the current NASH patient journey; understand how patient and physician challenges align and consider ways in which current tools and therapies may be optimised.

ExCeL London
Royal Victoria Dock
1 Western Gateway
E16 1XL

Become a CPD Provider
Want to see your company here?Become a CPD Provider